Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
I no longer have any affiliation with the bank and therefore I aim to derive a facts-based analysis, whilst any views expressed here do not represent investment advice or the views of my former employer
Lilly's next-gen Triple G (GLP-1/GIP/glucagon) agonist (Phase 1b, Phase 2): started recruiting for a Phase 3 trial this year approvals are expected by 2026
Its molecular formula is CHNO with a molecular weight of 873.0 g/mol
10/10 highly recommend
Exclusion criteria were: (1) case reports, conference abstracts, or editorials
US$ 28.99
US$ 29.76
US$ 22.15
US$ 25.23
US$ 29.82
US$ 27.63
